SoVote

Decentralized Democracy

House Hansard - 104

44th Parl. 1st Sess.
September 28, 2022 02:00PM
  • Sep/28/22 7:46:36 p.m.
  • Watch
Madam Speaker, I apologize to the member if he feels as though his question has not been addressed. Hopefully the comments that I provide tonight will suffice. Our government recognizes the strengths of Taiwan in matters of science, technology and innovation. The government is also aware of the issue of concern regarding the classification of Taiwan in the Canadian Common CV system used by Canada's federal research funding agencies and administered by the Canadian Institutes of Health Research, or CIHR. Currently, the Canadian Common CV system and CIHR's grant management platform adhere to the International Organization for Standardization country list. This list is recognized by the Government of Canada through Canada's national accreditation body, the Standards Council of Canada. However, the CIHR has had discussions on the matter of concern with key partners, including Global Affairs Canada and other federal stakeholders. As a result, CIHR is now actively implementing the change to Taiwan in its system to ensure ongoing alignment with Canada's foreign policy and government-wide data standards. We certainly recognize that this is an important concern not only for Taiwanese students and researchers in Canada, but also for many of their colleagues and partners throughout the broader research community and beyond. As members may know, there are very strong connections between the people of Canada and Taiwan, including in the scientific domain. Indeed, I am very pleased to note that our government engages directly with Taiwan on matters of scientific research collaboration through several mechanisms. For instance, the CIHR collaborates with Taiwan's ministry of science and technology, including through participation in multilateral research consortia. In addition, the CIHR recently worked with the Taipei Economic and Cultural Office in Ottawa to promote one of these initiatives, the Transcan-3 funding program, to support cancer researchers in Canada and Taiwan. These collaborative efforts speak to the many invaluable linkages between Canada and Taiwan. Through our government's ongoing engagement with Taiwan in areas that include health research partnership, we look forward to strengthening even further these ties of collaboration. Let me also emphasize that in the promotion of funding programs and its other engagements, CIHR has referred to and will continue to refer to our partner by the name of “Taiwan” simply. It is my hope that our ongoing partnership with Taiwanese counterparts, driven by our common values and shared priorities, will continue to yield impactful results for our collective health, well-being and prosperity.
412 words
  • Hear!
  • Rabble!
  • star_border